5% Off
Protet-IG250 IU/ml
Incepta Pharmaceuticals Ltd.
৳926.25
Out Of Stock
Generic medicine
Human Tetanus Immunoglobulin: Brands, Price & Uses in Bangladesh
Human Tetanus Immunoglobulin is a passive immunizing agent used in the prevention and management of tetanus.
About Human Tetanus Immunoglobulin
Indications of Human Tetanus Immunoglobulin
Human Tetanus Immunoglobulin is a passive immunizing agent used in the prevention and management of tetanus.
Established / Approved Uses
- Post-exposure tetanus prophylaxis: Given after an injury (especially tetanus-prone wounds such as deep, contaminated, devitalized, or puncture wounds) in patients whose tetanus immunization history is incomplete, uncertain, or unknown, in combination with wound care and, where indicated, tetanus toxoid vaccine.
- Treatment of clinical (active) tetanus: Used as part of the combined management of diagnosed tetanus infection, together with wound debridement, antimicrobial therapy, airway/muscle spasm control, and supportive intensive care. Clinical trial evidence of benefit is limited, but it remains a standard-of-care adjunct recommended by treatment guidelines.
Important Note
Human Tetanus Immunoglobulin provides only immediate, temporary (passive) protection against tetanus toxin. It does not replace active immunization; a course of tetanus toxoid-containing vaccine should be initiated or completed as appropriate, per standard wound-management and immunization protocols.
Dosage & Administration of Human Tetanus Immunoglobulin
Tetanus Prophylaxis (Wound Management)
| Population | Dose |
|---|---|
| Adults and children ≥ 7 years | 250 units, single dose, by deep intramuscular injection |
| Children < 7 years | Approximately 4 units/kg body weight by deep intramuscular injection (a full 250-unit dose is commonly used regardless of exact weight, as advised by the treating physician) |
| Delayed treatment or heavily contaminated wounds | Higher doses (e.g., up to 500 units) may be considered at the physician's discretion |
If tetanus toxoid vaccine is also indicated, it should be given concurrently but at a separate injection site with a separate syringe (see Administration).
Treatment of Active (Clinical) Tetanus
Dosing is individualized by the treating specialist according to disease severity, as part of a comprehensive treatment protocol (wound debridement, antimicrobial therapy, spasm control, airway management, and supportive care); substantially higher doses than the prophylactic dose are generally used. Human Tetanus Immunoglobulin should only be administered for this indication under hospital/specialist supervision.
Administration
For intramuscular injection only. Do not administer intravenously. Inspect visually for particulate matter or discoloration before use; do not use if the solution is turbid or has been frozen.
Side Effects of Human Tetanus Immunoglobulin
Most reactions to Human Tetanus Immunoglobulin are mild and self-limited.
Common
- Pain, tenderness, redness, or swelling at the injection site
- Mild, transient fever
- Headache, malaise
Uncommon / Rare
- Angioedema, urticaria, or other hypersensitivity reactions
- Anaphylactic/anaphylactoid reactions (rare, more likely in IgA-deficient individuals - see Contraindications)
- Nephrotic syndrome (rare, reported with immunoglobulin products)
- Thromboembolic events (rare; see Precautions and Warnings)
Contraindications of Human Tetanus Immunoglobulin
Human Tetanus Immunoglobulin is contraindicated in patients with:
- Known history of severe hypersensitivity (including anaphylaxis) to Human Tetanus Immunoglobulin or to any component of the preparation, or to other human immunoglobulin products.
- Selective IgA deficiency with known antibodies against IgA, due to the risk of severe hypersensitivity/anaphylactic reactions.
Frequently Asked Questions about Human Tetanus Immunoglobulin
What is Human Tetanus Immunoglobulin used for?
Human Tetanus Immunoglobulin is used to give immediate, short-term protection against tetanus - either as prophylaxis after an injury in people whose tetanus vaccination status is incomplete or unknown, or as part of the treatment of an active tetanus infection.
How is Human Tetanus Immunoglobulin different from the tetanus vaccine (toxoid)?
The tetanus vaccine trains your own immune system to make antibodies over several weeks, giving long-lasting protection. Human Tetanus Immunoglobulin supplies ready-made antibodies that act immediately but only last a few weeks, so it does not replace the vaccine - both are often given together at different injection sites.
How is Human Tetanus Immunoglobulin given?
It is given as a single intramuscular (into the muscle) injection by a healthcare professional. It should never be given intravenously.
Who should not receive Human Tetanus Immunoglobulin?
Human Tetanus Immunoglobulin should not be given to anyone with a known severe allergic reaction to it or to other human immunoglobulin products, or to people with selective IgA deficiency who have antibodies against IgA, because of the risk of severe allergic (anaphylactic) reactions.
Is Human Tetanus Immunoglobulin safe during pregnancy or breastfeeding?
Human Tetanus Immunoglobulin should be used in pregnancy only if clearly needed, when the benefit of protecting against tetanus outweighs any potential risk; a physician should be consulted. It should also be used in breastfeeding mothers only under medical advice.
What are the common side effects of Human Tetanus Immunoglobulin?
Most people experience only mild soreness, redness, or swelling at the injection site, or a slight, temporary fever. Serious reactions such as severe allergic reactions are rare.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.